You are viewing: Australia Nuclear Medicine Equipment Market analysis

The Australia Nuclear Medicine Equipment Market was valued at $87.2 Million in 2025 and projected to reach to $113.1 Million by 2030, representing a compound annual growth rate of 5.3%. Australia's nuclear medicine equipment market is experiencing robust growth driven by continuous modernization of the nation's healthcare infrastructure and increasing adoption of advanced diagnostic imaging technologies.

Australia Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Nuclear Medicine Equipment Market Trends and Insights

  • Australia's healthcare infrastructure continues to modernize, with increasing adoption of diagnostic imaging technologies driving demand for nuclear medicine equipment across hospitals and diagnostic centers.
  • The market growth in Australia reflects rising prevalence of chronic diseases, aging population demographics, and enhanced government funding for advanced medical imaging capabilities. The Australian nuclear medicine equipment sector benefits from strong regulatory frameworks and established reimbursement pathways that support equipment procurement.
  • Australia's commitment to healthcare innovation and the expansion of nuclear medicine departments in major metropolitan and regional hospitals are key contributors to market expansion through 2030.
  • Investment in radiopharmaceutical production facilities and training programs further strengthens Australia's position in the Asia Pacific nuclear medicine equipment landscape..

Key Market Statistics

  • CAGR (2025-2030) 5.3% CAGR
  • Market Size, 2025 ~USD 87.2 Million
  • Forecast, 2030 ~USD 113.1 Million
  • Country Australia

Australia Nuclear Medicine Equipment Market Overview

Market Valuation :

Australia's nuclear medicine equipment market is valued at $87.2 million in 2025, with strong growth trajectory positioning it as a key healthcare technology segment in the Asia-Pacific region.

Growth Momentum :

The market is expanding at a CAGR of 5.3% through 2030, outpacing the global average of 4.62%, driven by modernization of Australian healthcare infrastructure and increased diagnostic imaging adoption.

Healthcare Infrastructure Investment :

Australian hospitals and diagnostic centers are increasingly investing in advanced nuclear medicine technologies, supported by government healthcare initiatives and rising demand for early disease detection capabilities.

Forecast Growth :

The market is projected to reach $113.1 million by 2030, representing a $25.9 million increase over five years, reflecting sustained demand for diagnostic imaging solutions across Australian healthcare facilities.

Australia Nuclear Medicine Equipment Market Dynamics

  • Hospitals and diagnostic centers across major cities are upgrading their facilities with state-of-the-art nuclear medicine equipment to enhance diagnostic capabilities and improve patient outcomes.
  • Government support for healthcare technology advancement and rising awareness of early disease detection benefits are key growth catalysts. Looking ahead to 2030, the market is expected to maintain its upward trajectory with expanding applications in oncology, cardiology, and neurology.
  • The aging Australian population and increasing prevalence of chronic diseases will drive sustained demand for nuclear medicine diagnostics.
  • Strategic partnerships between healthcare providers and equipment manufacturers, combined with technological innovations in imaging resolution and patient safety, will further accelerate market expansion throughout the forecast period..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Australia's nuclear medicine equipment market is valued at $87.2 million in 2025 and will reach $113.1 million by 2030.
    • Australia demonstrates a 5.3% CAGR, outpacing the global average of 4.62%, indicating strong regional demand.
    • Australia's aging population and rising chronic disease prevalence are primary drivers of nuclear medicine equipment adoption.
    • Australia's robust regulatory environment and reimbursement systems support sustained market growth through 2030.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    Australia Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    AUSTRALIA: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS11.812.513.21414.815.616.517.45.7
    DIAGNOSTIC IMAGING CENTERS17.118.119.220.421.622.924.225.76
    HOSPITALS41.443.645.948.350.853.456.2595.1
    OTHER END USERS88.48.89.29.710.110.6114.6
    TOTAL78.382.787.291.996.8102107.4113.15.3

    Target Audience

    • Hospital & Diagnostic Center Administrators : Need market data to justify capital expenditures on nuclear medicine equipment upgrades, benchmark against industry standards, and plan facility modernization aligned with market growth trends in Australia.
    • Medical Device Manufacturers & Distributors : Require detailed market sizing, growth forecasts, and competitive insights to develop go-to-market strategies, identify distribution opportunities, and assess market potential for nuclear medicine equipment in Australia.
    • Healthcare Investment Firms & Private Equity : Need comprehensive market analysis to evaluate investment opportunities in Australian healthcare technology, assess portfolio company growth potential, and identify acquisition targets in the nuclear medicine sector.
    • Government & Healthcare Policy Makers : Utilize market intelligence to inform healthcare infrastructure planning, allocate funding for diagnostic imaging capabilities, and develop policies supporting adoption of advanced nuclear medicine technologies across Australia.
    • Consulting & Market Research Professionals : Require authoritative Australia-specific data to support client advisory services, validate market assumptions, and provide evidence-based recommendations for healthcare technology investments and strategic planning.

    Key Companies in the Australia Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise valuation of Australia's nuclear medicine equipment market ($87.2M in 2025) with detailed CAGR analysis (5.3%) and five-year forecasts to support investment decisions and business planning.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to Australia's healthcare sector, including key players, market share distribution, and strategic positioning within the Asia-Pacific region's diagnostic imaging market.
    • Regional Growth Drivers : Identify Australia-specific growth catalysts including healthcare infrastructure modernization, government initiatives, aging population demographics, and increasing adoption of advanced diagnostic technologies in hospitals and clinics.
    • Investment & Expansion Strategy : Leverage country-specific insights to develop targeted market entry strategies, identify high-growth segments within Australian healthcare, and optimize resource allocation for maximum ROI in the region.
    • Stakeholder Decision Support : Equip executives, investors, and healthcare administrators with Australia-focused market intelligence to support procurement decisions, capital investments, and strategic partnerships in the nuclear medicine equipment sector.

    Frequently asked questions

    What is the current size of Australia's nuclear medicine equipment market?

    Australia's nuclear medicine equipment market is valued at $87.2 million in 2025.

    What is the projected market size for Australia by 2030?

    Australia's nuclear medicine equipment market is projected to reach $113.1 million by 2030.

    What is Australia's market growth rate for nuclear medicine equipment?

    Australia's nuclear medicine equipment market is growing at a CAGR of 5.3% from 2025 to 2030.

    What factors are driving growth in Australia's nuclear medicine equipment market?

    Key drivers include Australia's aging population, rising chronic disease prevalence, government healthcare funding, and expansion of nuclear medicine departments in hospitals.

    How does Australia's market growth compare to global trends?

    Australia's 5.3% CAGR exceeds the global average of 4.62%, demonstrating stronger regional market momentum.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status